Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments for resistant alopecia areata were equally effective.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

Triamcinolone is more effective and safer for treating feline pemphigus foliaceus than prednisone.

Intralesional steroid injections are safe and effective for treating severe alopecia areata.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Intralesional steroid therapy is useful for treating various skin conditions.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Smaller, diluted corticosteroid injections reduce the risk of vision loss.

COVID-19 infection may trigger alopecia areata in some patients.

Sun exposure after laser hair removal can cause skin darkening, which is hard to treat and requires avoiding UV light.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Corticosteroid injections for hair loss can cause skin thinning.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.